Importantly, these efforts include a fully annotated clinical database and biospecimen bank of NF1-associated MPNST primary tumors, cell lines, and novel patient-derived xenografts (PDXs), which are available on request. This evidence concerns the gene NF1 and malignant peripheral nerve sheath tumor.